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Background: Chlamydia trachomatis prevalence among 12–17-year-old adolescents in Germany was 
determined in the present study.  
 
Methods: A random age-stratified sample of 1815 urine specimens of boys and girls was selected 
from a population-based nationwide health survey conducted in 2003–06. Urine samples were pooled 
and tested for chlamydia using strand displacement amplification. Positive pools were individually 
retested. Prevalence, prevalence ratios (PR) and corresponding 95% confidence intervals (CI) were 
calculated. Associations between infection and socio-demographic factors (age, sex, place of 
residence), sexual activity (defined by oral contraceptive use or gynaecologist visits) and abdominal 
pain among females were examined in univariate analysis.  
 
Results: Sixteen samples (0.9% 95% CI: 0.5–1.3%), all from 15–17-year olds, were positive for 
chlamydia. Prevalence increased with age to 2% (95% CI: 0.8–3.2%) among 17 year olds and was 
higher among girls than boys (1.8% v. 0.1%; P < 0.001). A total of 4.6% (95% CI: 1.4–7.7%) of 
sexually active girls aged 17 were infected and 5/7 of them had no regular abdominal pain. Of all girls 
with abdominal pains, 52% had visited gynaecologists. Prevalence of infection was higher among 
those with pains than those without (PR = 3.8, 95% CI: 1.3–11.0).  
 
Conclusions: This is the first nationwide study based on a representative sample of boys and girls to 
measure chlamydia prevalence among adolescents in Germany. Prevalence in Germany is consistent 
with other countries. Among sexually active females, prevalence was comparable to screening 
thresholds. As gynaecological visits were common among females, we recommend that 
gynaecologists should actively offer screening to sexually active females, which would strengthen the 





Chlamydia trachomatis is worldwide the most common sexually transmissible bacterial infection 
especially among women and men aged 16–19 and 20–24, respectively. Although chlamydia is not 
notifiable in Germany, it is the most frequently reported disease in German sentinel surveillance. 
1
 
There are, however, no representative data for chlamydia prevalence in Germany. For women, a 
prevalence of 6.5% among ≤20 year olds attending gynaecologists and 6.4% among sexually active 






 A nationwide health survey, based 
on a representative sample of individuals aged 0–17 years, was conducted across Germany in 2003–
06. 
4
 We tested urine collected during the survey to estimate chlamydia prevalence among 
  






We selected an age-stratified random sample of 1815 from 5755 boys and girls aged 12–17 years. 
Urine samples were tested for chlamydia using strand displacement amplification (BD ProbeTec ET 
System; Franklin Lakes, NJ, USA). Assays were carried out according to the manufacturer’s 
instructions, except 500 µL instead of 4 mL was used. Based on the expected low prevalence and to 
save costs, samples were pooled by four. Urine samples from positive or inhibitory pools were 
individually retested. 
Socio-demographic factors (age, sex, residence, alcohol consumption and smoking habits), sexual 
activity proxies for girls (defined by oral contraceptive (OC) use or gynaecologist visits) and potential 
symptoms (regular abdominal pains) were extracted from the survey database. STATA (version 10; 
Stata Corporation, College Station, TX, USA) was used to calculate prevalence, prevalence ratios 
(PR) and corresponding 95% confidence intervals (CI) and examine associations between risk factors 




All selected urine samples were collected in 2005–06. A total of 1807 samples were successfully 
tested, of which 952 (53%) belonged to men. A considerable proportion had smoked (27%) or 
regularly consumed alcohol (>1 glass/week) (28%). By the age of 17, 37% were assumed to be 
sexually active. 52% of all women with regular abdominal pains had visited gynaecologists. 
Chlamydia prevalence was 0.9% (95% CI: 0.5–1.3%) among 12–17-year olds in 2005–06; all positive 
were aged 15–17 (Table 1). 
Prevalence increased with age to 2% (95% CI: 0.8–3.2%) among 17 year olds and was significantly 
higher among girls than boys (1.8% v. 0.1%, P < 0.001). Girls aged 17 were at 10-fold higher risk of 
infection than boys of the same age (P = 0.005). Prevalence was higher among girls with abdominal 
pains than those without (PR = 3.8, 95% CI: 1.3–11.0). Among sexually active girls aged 15, 3.6% 
(95% CI: –3.8 to 10.9%) were infected, which rose to 4.6% (95% CI: 1.4–7.7%) among those aged 17. 
Five from seven had no abdominal pains. 
Restriction of analysis to females aged 17 found no correlation between education level, drug, 
cigarette and alcohol consumption and increased risk of chlamydia. Although prevalence was higher 
among OC users (PR = 1.2, 95% CI: 0.4–4.1), gynaecologist visits (PR = 2.4, 95% CI: 0.5–11.0), and 






The overall prevalence in our population was low and increased with age, which is closely linked to 
sexual debut. A German study found that 11% of girls at 14 were sexually active, which increased to 
66% at age 17. 
5
 Consistent with population-based prevalence from the UK and Netherlands (3.8% 






 prevalence was high among girls in 
this study; while being very low among boys. Young females may seek older male partners, with 
whom they have earlier sexual onset and less likely to use contraceptives than peers with boyfriends 
of a similar age. 
8
 Many girls visiting gynaecologists had regular abdominal pains, which although are 
unspecific symptoms, could be indicative for undetected chlamydia. Among sexually active females 
prevalence was comparable to screening thresholds of 3–10%, thus warranting screening in this 
group. 
  
It is possible that the use of pooled urine samples, as proposed by the recently implemented screening 
program in Germany, may affect testing quality. 
9
 Due to limited availability, less urine than 
recommended was used. Urine samples were not first void, which is preferred as they contain the 
greatest concentration of chlamydial elementary bodies. With each following void, the number of 
positives that can be detected may decrease. 
10
 Urine also contains less chlamydia than cervical 
swabs, which were used in the Berlin studies, and may partly explain their higher prevalence rates. 
Together these factors may have influenced the prevalence in our population. 
Despite limitations, these findings provide the first representative prevalence rates among young 
adolescents in Germany. As gynaecological visits were common among females, we recommend that 
gynaecologists should actively offer screening to sexually active girls. A similar study is required 
among young adults to provide prevalence among men and further improve the evidence-base for 
screening in Germany. 
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